Matthew McKay, MD
Interventional Cardiology · Bangor, MENPI 1871564468
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,554 of the $3,905 with a category attached, or 65.4%. 4 manufacturers reported payments, led by Ancora Heart, Inc. at 53.7% of the total. Reporting peaked in 2023 at $2,111 and has fallen 91.1% since, to $187 in 2025.
Across 44 payments — averaging $88.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ancora Heart, Inc.$2K
- Boston Scientific$1K
- Edwards Lifesciences$697
- W. L. Gore & Associates, Inc.$14
What the payments were for
- Travel & lodging$2,55465%
- Food & beverage$1,35135%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ancora Heart, Inc. | 9 | $2,097 |
| Boston Scientific | 4 | $1,098 |
| Edwards Lifesciences | 30 | $697 |
| W. L. Gore & Associates, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AccuCinch$1,953
- Watchman$1,098
- SAPIEN 3 Ultra RESILIA$119
How this compares
$3,905 in reported general payments places this provider in the 70th percentile of 21 interventional cardiology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 30 | $37,274 |
| Praluent PenAlirocumab | 13 | $6,242 |
| Metoprolol Succinate | 16 | $376 |
| Ezetimibe | 14 | $140 |
| ClopidogrelClopidogrel Bisulfate | 18 | $82 |
| Lisinopril | 17 | $53 |
| Spironolactone | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Bangor
- Srikanth RadhakrishnanBangor$7K
- Thomas EarlBangor$3K
- Harsh MehtaBangor$2K
- Paul Vom EigenBangor$86
- Szymon WiernekScarborough$22K
- Arun ThukkaniLewiston$8K
- Ellie MuellerAugusta$6K
- Jay ShahScarborough$5K
- Bryce EinhornLewiston$5K
- Peter HigginsLewiston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.